RAYMOND JAMES FINANCIAL INC·4

Feb 23, 3:28 PM ET

Begor Mark W 4

4 · RAYMOND JAMES FINANCIAL INC · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Raymond James (RJF) Director Mark Begor Receives Award of 1,303 DRSUs

What Happened Mark W. Begor, a director of Raymond James Financial (RJF), received a grant of 1,303 deferred restricted stock units (DRSUs) on February 19, 2026. The grant is reported as an award (transaction code A) with a reported acquisition price of $0.00 (value shown as $0). This was an annual non‑executive director compensation award, not an open‑market purchase or sale.

Key Details

  • Transaction date: 2026-02-19; Form 4 filed: 2026-02-23 (timely — within the required reporting window).
  • Security/amount: 1,303 Deferred Restricted Stock Units (DRSUs); reported acquisition price $0.00.
  • Shares owned after transaction: not specified in the provided filing.
  • Footnotes: DRSUs convert 1-for-1 into shares upon vesting and include accrued cash in lieu of dividends. They vest at the next annual shareholders meeting (but no later than March 15 of the calendar year following the grant). Begor made an irrevocable election to defer settlement until he leaves the board.
  • Filing context: part of the registrant’s annual grant to non‑executive directors.

Context DRSUs are a form of deferred equity compensation — they do not deliver actual shares until they vest and are settled (here, settlement is further deferred until board service ends). Such grants are routine for non‑executive directors and reflect compensation, not a market purchase that signals immediate insider conviction.

Insider Transaction Report

Form 4
Period: 2026-02-19
Begor Mark W
Director
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-02-19+1,3032,285 total
Footnotes (2)
  • [F1]Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the date the reporting person terminates his or her service on the Board of Directors.
  • [F2]Includes DRSUs.
Signature
/s/ Mark W. Begor by Jonathan J. Doyle as Attorney-in-Fact|2026-02-23

Documents

1 file
  • 4
    doc4.xmlPrimary